Search
for

    Sort by

    Research 121–150 of 1000+

    1. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients Journal of The American Academy of Dermatology · 2016 · 238 citations
    2. Tofacitinib for the treatment of alopecia areata and variants in adolescents Journal of the American Academy of Dermatology · 2016 · 139 citations
    3. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study Journal of The American Academy of Dermatology · 2021 · 66 citations
    4. Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib British Journal of Dermatology · 2023 · 17 citations
    5. Janus Kinase Inhibitors for Alopecia Areata JAMA network open · 2023 · 12 citations
    6. Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report Clinical Cosmetic and Investigational Dermatology · 2026
    7. Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report DOAJ (DOAJ: Directory of Open Access Journals) · 2026
    8. Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies American Journal of Clinical Dermatology · 2026
    9. Updated Integrated Efficacy Analysis of Ritlecitinib Up to 3 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials SKIN The Journal of Cutaneous Medicine · 2025
    10. Nanostructured Ayurvedic Emulsion of Bakuchiol & Neem Oil for Mild‑to‑Moderate Alopecia Areata Open‑Label Single‑Arm Pilot Study 2025
    11. Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata Cureus · 2025
    12. Comparing the Efficacy of Weekly Azathioprine Pulse versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata Pakistan Journal of Health Sciences · 2025
    13. Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center The Journal of Dermatology · 2025
    14. Comparison of efficacy of intralesional triamcinolone versus 308nm Excimer laser in the treatment of localized alopecia areata Journal of Pakistan Association of Dermatologists · 2024
    15. 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata Journal of the American Academy of Dermatology · 2024
    16. Alopecia Areata Treated with Homoeopathic Preparation of Phosphorus: Two Evidence-Based Case Reports Homœopathic Links · 2024
    17. PRP versus intralesional triamcinolone for alopecia areata comparative study International Journal of Dermatology Research · 2024
    18. Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients Journal of The American Academy of Dermatology · 2023
    19. Successful Treatment of Alopecia Totalis with Topical Calcipotriol: Serial Case Report and Review of the Literature 2020
    20. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study. PubMed · 2015 · 38 citations
    21. How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach Dermatology and Therapy · 2026
    22. Update on pulse corticosteroid therapy for the management of alopecia areata JEADV Clinical Practice · 2024 · 1 citations
    23. P165 Real-world experience of ritlecitinib for the treatment of alopecia areata from an alopecia clinic in a large tertiary dermatology centre British Journal of Dermatology · 2026
    24. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study Dermatology · 2018 · 66 citations
    25. Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial Pediatric Dermatology · 2023 · 48 citations
    26. Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers 2021 · 36 citations
    27. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) American Journal of Clinical Dermatology · 2023 · 20 citations
    28. Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8‐methoxypsoralen application Photodermatology, photoimmunology & photomedicine · 2011 · 12 citations
    29. Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial Dermatologic Therapy · 2022 · 8 citations
    30. II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata Anais Brasileiros de Dermatologia · 2024 · 5 citations